I mentioned it before, NGIO will open doors .....Joe mentioned AE37 results "off the charts good" (post 8566).. GNBT holding need funds to move forward , I prefer some dilution and cash versus stalling progress. Any positive clinical trial ph2 update will take care of business and the "shorts" will take care of GNBT pps.
We need a KRTX chart !!
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links